Skip To Main Content
Sandi Wong on Muck Rack

Sandi Wong

  • Medical Writer, Vaniam Group
South San Francisco
As seen in: KCRA-TV (Sacramento, CA), MyRGV, BioCentury
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sandi

Contact Sandi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Kojin launches to exploit ferroptosis-vulnerable cancer cell state

|
By Sandi Wong
| BioCentury Verified
Emerging Company Profile Emerging Company Profile: Kojin to use Polaris, Newpath, Cathay-led $60M A round to develop ferroptosis-based cancer therapies Kojin launches with co-founders including Schreiber, Cravatt and a $60 million series A to develop cell state-based therapeutics By Sandi Wong, Assistant Editor Jun 10, 2021 | 8:52 PM GMT Kojin, which launched Wednesday with a $60 million series A led by Polaris Partners, Newpath Partners and Cathay Health, Read the full 736 word article
Open in Who Shared Issue with article?

Going beyond genetic medicines for muscular dystrophy

|
By Sandi Wong
| BioCentury Verified
Targets & Mechanisms Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones Muscular dystrophy programs in the clinic cover not only a range of muscle mechanisms but also anti-fibrotic and anti-inflammation ones.
Open in Who Shared Issue with article?

WHO meeting highlights correlates of protection questions for next-gen COVID vaccines

|
By Sandi Wong
| BioCentury Verified
Product Development By Sandi Wong, Assistant Editor May 28, 2021 | 1:20 AM GMT A Wednesday meeting hosted by WHO seeking to clarify the next steps in defining correlates of protection for next-generation COVID-19 vaccines underscored the need to determine if prediction thresholds can be harmonized across modalities and whether serum markers are valid predictors of efficacy for vaccines aiming for strong mucosal immunity.
Open in Who Shared Issue with article?
See all 1,535 articles